Cargando…

2023 Vascular Research Initiatives Conference: Structural and Immune Cells in Vascular Disease

The 2023 Vascular Research Initiatives Conference (VRIC) was held in Boston, Massachusetts, and coincided with the first day of Vascular Discovery 2023, hosted by the American Heart Association. VRIC attracts vascular clinicians, surgeon-scientists, and basic science researchers to a common arena to...

Descripción completa

Detalles Bibliográficos
Autores principales: Thaxton, Carly, Gallagher, Katherine, Dardik, Alan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463243/
https://www.ncbi.nlm.nih.gov/pubmed/37649474
http://dx.doi.org/10.1016/j.jvssci.2023.100117
_version_ 1785098186539401216
author Thaxton, Carly
Gallagher, Katherine
Dardik, Alan
author_facet Thaxton, Carly
Gallagher, Katherine
Dardik, Alan
author_sort Thaxton, Carly
collection PubMed
description The 2023 Vascular Research Initiatives Conference (VRIC) was held in Boston, Massachusetts, and coincided with the first day of Vascular Discovery 2023, hosted by the American Heart Association. VRIC attracts vascular clinicians, surgeon-scientists, and basic science researchers to a common arena to facilitate the exchange of basic and translational science to stimulate and inspire participants to study and find solutions to vascular conditions. The theme of the conference this year was “Structural and Immune Cells in Vascular Disease.” Abstract sessions focused on venous disease, vascular regeneration, stem cells and wound healing, aortopathies, and the role of the immune system in atherosclerosis. A moderated translational science panel included talks from Dr Chiara Giannarelli and Dr Bhama Ramkhelawon. Recipients of Society for Vascular Surgery partner grants and National Institutes of Health K08 awardees presented their progress reports, and the Resident Research and VRIC Trainee Awardees were acknowledged. The Alexander W. Clowes Distinguished Lecture, entitled “Co-stimulatory Immune Checkpoints in Atherosclerosis: Novel Immunotherapeutic Targets to Combat Atherosclerotic Cardiovascular Disease” was given by Dr Ester Lutgens. VRIC continues to foster interdisciplinary collaborations across the translational field of vascular disease.
format Online
Article
Text
id pubmed-10463243
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-104632432023-08-30 2023 Vascular Research Initiatives Conference: Structural and Immune Cells in Vascular Disease Thaxton, Carly Gallagher, Katherine Dardik, Alan JVS Vasc Sci Article The 2023 Vascular Research Initiatives Conference (VRIC) was held in Boston, Massachusetts, and coincided with the first day of Vascular Discovery 2023, hosted by the American Heart Association. VRIC attracts vascular clinicians, surgeon-scientists, and basic science researchers to a common arena to facilitate the exchange of basic and translational science to stimulate and inspire participants to study and find solutions to vascular conditions. The theme of the conference this year was “Structural and Immune Cells in Vascular Disease.” Abstract sessions focused on venous disease, vascular regeneration, stem cells and wound healing, aortopathies, and the role of the immune system in atherosclerosis. A moderated translational science panel included talks from Dr Chiara Giannarelli and Dr Bhama Ramkhelawon. Recipients of Society for Vascular Surgery partner grants and National Institutes of Health K08 awardees presented their progress reports, and the Resident Research and VRIC Trainee Awardees were acknowledged. The Alexander W. Clowes Distinguished Lecture, entitled “Co-stimulatory Immune Checkpoints in Atherosclerosis: Novel Immunotherapeutic Targets to Combat Atherosclerotic Cardiovascular Disease” was given by Dr Ester Lutgens. VRIC continues to foster interdisciplinary collaborations across the translational field of vascular disease. Elsevier 2023-07-10 /pmc/articles/PMC10463243/ /pubmed/37649474 http://dx.doi.org/10.1016/j.jvssci.2023.100117 Text en © 2023 by the Society for Vascular Surgery. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Thaxton, Carly
Gallagher, Katherine
Dardik, Alan
2023 Vascular Research Initiatives Conference: Structural and Immune Cells in Vascular Disease
title 2023 Vascular Research Initiatives Conference: Structural and Immune Cells in Vascular Disease
title_full 2023 Vascular Research Initiatives Conference: Structural and Immune Cells in Vascular Disease
title_fullStr 2023 Vascular Research Initiatives Conference: Structural and Immune Cells in Vascular Disease
title_full_unstemmed 2023 Vascular Research Initiatives Conference: Structural and Immune Cells in Vascular Disease
title_short 2023 Vascular Research Initiatives Conference: Structural and Immune Cells in Vascular Disease
title_sort 2023 vascular research initiatives conference: structural and immune cells in vascular disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463243/
https://www.ncbi.nlm.nih.gov/pubmed/37649474
http://dx.doi.org/10.1016/j.jvssci.2023.100117
work_keys_str_mv AT thaxtoncarly 2023vascularresearchinitiativesconferencestructuralandimmunecellsinvasculardisease
AT gallagherkatherine 2023vascularresearchinitiativesconferencestructuralandimmunecellsinvasculardisease
AT dardikalan 2023vascularresearchinitiativesconferencestructuralandimmunecellsinvasculardisease